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Diaphragm activationWe explored whether maternal exercise during pregnancy moderates the effect of fetal breathing move-
ments on fetal cardiac autonomic control assessed by metrics of heart rate (HR) and heart rate variability
(HRV). Thirty women were assigned to Exercise or Control group (n=15/group) based on the modiﬁable
physical activity questionnaire (MPAQ). Magnetocardiograms (MCG) were recorded using a dedicated fetal
biomagnetometer. Periods of fetal breathing activity and apnea were identiﬁed using the fetal diaphragmatic
magnetomyogram (dMMG) as a marker. MCG R-waves were marked. Metrics of fetal HR and HRV were com-
pared using 1 breathing and1 apneic epoch/fetus. The main effects of group (Exercise vs. Control) and condi-
tion (Apnea vs. Breathing) and their interactions were explored. Fetal breathing resulted in signiﬁcantly
lower fetal HR and higher vagally-mediated HRV. Maternal exercise resulted in signiﬁcantly lower fetal HR,
higher total HRV and vagally-mediated HRV with no difference in frequency band ratios. Signiﬁcant interac-
tions between maternal exercise and fetal breathing were found for metrics summarizing total HRV and a
parasympathetic metric. Post hoc comparison showed no group difference during fetal apnea. Fetal breathing
was associated with a loss of Total HRV in the Control group and no difference in the Exercise group. Both
groups show enhanced vagal function during fetal breathing; greater in the Exercise group. During in utero
breathing movements, the fetus of the exercising mother has enhanced cardiac autonomic function that
may give the offspring an adaptive advantage.
© 2011 Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.1. Introduction
Fetal breathing movements have been characterized using bio-
magnetometry by our group [1] and others [2]. Ulusar et al. used si-
multaneous ultrasound to identify and quantify fetal breathing
movements and identiﬁed a sinusoidal waveform linked to the
breathing movements seen on ultrasound. Recently, an automatic al-
gorithmwas developed that identiﬁes spectral peaks in the fetal mag-
netocardiogram (MCG) interbeat interval (IBI) time-series consistent
with fetal respiratory sinus arrhythmia (RSA) [3]. These recent devel-
opments in the ﬁeld of fetal biomagnetometry allow for the investiga-
tion of neural integration of central circuits that govern fetal cardiac
autonomic control.
We independently observed what we termed the fetal diaphrag-
matic magnetomyogram (dMMG) in maternal-fetal MCG recordings
[1]. We then used the dMMG as marker of fetal breathing activity inical Center, Hoglund Brain Im-
ity, KS 66160, USA. Tel.: +1
on).
 CC BY-NC-ND license.order to compare fetal cardiac autonomic control during breathing
and non-breathing epochs (apnea) in the active fetal states. We
found that fetal breathing activity resulted in signiﬁcantly lower
heart rate (HR) and higher heart rate variability (HRV), particularly
in those metrics inﬂuenced by parasympathetic input. Our next goal
was to use this method to compare fetal HR and HRV in two groups
of women; those who performed moderate intensity exercise during
pregnancy and those who did not.
In the non-pregnant population, exercise has many documented
effects including improved glucose tolerance, increased insulin sensi-
tivity, improved endothelial function, increased parasympathetic
tone and reduced inﬂammation. Exercise also has been found to
have many positive maternal effects related to pregnancy and deliv-
ery; for example, shorter labor and delivery times, faster recovery
after delivery, decreased discomforts of pregnancy and fewer preg-
nancy complications [4]. Currently, the American Congress of Obstet-
rics and Gynecology (ACOG) guidelines suggest that pregnant women
participate in aerobic activity at moderate to vigorous intensities
most days of the week for 30 or more minutes [5]. Given the grave
health care concerns surrounding maternal obesity, fetal over-
nutrition, and the potential heritability of obesity, insulin resistance
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ing pregnancy may be an important intervention strategy that could
improve offspring cardiovascular health and reduce the prevalence
of inherited obesity. While the beneﬁts of exercise for pregnant
women are well documented, the effects on the developing cardio-
vascular system of the fetus are less well understood.
Previously, we reported that regular aerobic maternal exercise
throughout pregnancy was associated with improved fetal cardiac au-
tonomic control [7]. In that prospective, longitudinal pilot study, we
found signiﬁcant differences in fetal HR and HRV at 36 weeks GA.
During active fetal states, fetal HR was lower by approximately 10
beats per minute (bpm) and HRV was higher in all time and frequen-
cy domain metrics if women exercised during pregnancy. During
quiet fetal states, power in the very low frequency (VLF, 0.02–
0.08 Hz) and high frequency (HF, 0.4–1.7 Hz) bands was signiﬁcantly
higher in the Exercise group. No group difference was observed for
any metric of fetal HR or HRV at the 28 or 32 week GA time points.
Following these studies, our next aim was to determine whether
maternal exercise moderates the effect of fetal breathing on cardiac
autonomic control as assessed by metrics of fetal HR and HRV. In
this retrospective analysis we used the fetal dMMG as a marker of
in utero breathing activity and explored the effects of maternal
group (Exercise, Control), fetal condition (Breathing, Apnea) and
their interactions.
2. Methods
2.1. Study population
Sixty-six pregnant women were part of a longitudinal, non-
blinded study designed to determine the effects of self-reported exer-
cise on fetal cardiac autonomic nervous system development. Fifty-
one of the 66 women enrolled in the pilot study remained enrolled
at 36 weeks GA; (24 Exercise, 27 Control). Because group differences
in fetal HR and HRV were previously found only at 36 weeks, this ret-
rospective analysis was limited to the 51 maternal-fetal data sets. All
protocols were approved by the Kansas City University of Medicine
and Biosciences and the University of Kansas Medical Center Institu-
tional Review Boards and Human Subjects Committees. Informed
consent was obtained from each participant. Women were tested be-
tween 10:00 and 17:00 hours. Women were assigned to the Exercise
group if they performed moderate to vigorous aerobic exercise
throughout their pregnancy for a minimum of 30 min, three times
per week. This criterion was based on the ACOG minimum recom-
mendation for women previously sedentary prior to pregnancy.
Women in the non-exercising group were below the minimum
ACOG requirements throughout their pregnancy. Reported pre-
pregnancy BMI of the womenwhose data were used in this retrospec-
tive analysis was [Mean (+/− 1 SD)]: Exercise group [23.4 (2.6)],
Control group [25.4 (5.9)]. All women carried singleton pregnancies
and delivered healthy, term infants.
2.2. Data acquisition
An ultrasound was obtained immediately prior to the MCG record-
ing in order to document the position of the fetal body and note the
presence or absence of fetal movements (breathing, mouthing or
body movements). Biomagnetic signals were recorded using an in-
vestigational 83 channel dedicated fetal biomagnetometer (CTF Sys-
tems, Inc.), housed in a magnetically shielded room. The axial
gradiometer sensors are spatially distributed to cover the gravid ma-
ternal abdomen. Pregnant subjects were comfortably seated, slightly
reclined and in contact with the surface of the biomagnetometer in-
terface without applying pressure to the abdomen. The data were ac-
quired in a continuous 18 minute recording using a 300 Hz sampling
rate and recording ﬁlter of 0–75 Hz.2.3. Data processing
Data were digitally ﬁltered between 0.5 and 40 Hz ofﬂine (bidirec-
tional fourth-order Butterworth ﬁlter) and then divided into 3 con-
secutive 6 minute sections for independent component analysis
(ICA). ICA is a blind-source separation technique used to segregate
the contributions from multivariate and spatially distinct electro-
physiological sources into individual components (e.g., maternal,
fetal, heart, diaphragm) [8,9] and was implemented in EEGLAB tool-
box (version 4.311) [10]. In order to construct the inter-beat interval
(IBI) series for frequency domain analysis, the fetal MCG was identi-
ﬁed and ﬁducial R-peaks were automatically detected using a
template-matching algorithm described in detail in May et al. [7].
Fetal activity state has a signiﬁcant inﬂuence on fetal HR and HRV,
therefore; all records undergo state classiﬁcation by visual inspection
of the fetal HR pattern [11] by two independent investigators (KMG/
LEM). States 1F (calm, non-REM) and 3F (calm wakefulness) associat-
ed with absent, sporadic or short-lasting HR accelerations were clas-
siﬁed as quiet states. States 2F (active REM) and 4F (active
wakefulness) with frequent, long-lasting accelerations that return to
the baseline were classiﬁed as active states [12]. While fetal breathing
occurs in both active (2F, 4F) and quiet (1F, 3F) states, the chance of
observing these movements is signiﬁcantly higher in the active states
[13]. If state determination differed between investigators, a third
opinion was sought and consensus was reached.
The ICA data were visually inspected for the fetal dMMG, a clearly
identiﬁable sinusoidal component (Fig. 1) described in detail in Gus-
tafson et al. [1]. Eleven records at 36 weeks GA were classiﬁed as
quiet states (n=6 Exercise, n=5 Control) and none of these showed
evidence of fetal dMMG activity. This left 40 active state records avail-
able for visual inspection of fetal dMMG activity and further HR and
HRV analysis (n=18 Exercise, n=22 Control). When observed, the
duration (time onset and offset) of the dMMG was marked and only
epochs greater than or equal to 1 min in duration were used in the
analysis of fetal HR and HRV. Non-breathing epochs (apnea) were de-
termined by selecting a silent region in the same component that im-
mediately preceded or followed the dMMG that was equal to the
duration of the breathing epoch. Epoch length ranged from 60.2 to
144.2 s; mean and standard deviation were 80.2+/−22.4 s. Fetal
HR and HRV were determined from the R-R intervals observed in
one breathing and one non-breathing epoch per fetus. Thirty (15 Ex-
ercise,15 Control) of the 40 records contained fetal dMMG activity
using the criteria we established. This represents 75% of the active
state datasets and 59% of the total sample at 36 weeks GA.
2.4. Analysis of fetal HR and HRV
To compare time-domain metrics during breathing and non-
breathing periods, the fetal IBI series was imported into QRSTool and
CMetX, a suite of freely available tools for transforming ECG/MCG data
to metrics of HRV [14] (http://www.psychoﬁzz.org). QRSTool provides
a graphical user interface that allows extraction of the interbeat interval
(IBI) series from theMCG data. CMetX calculates several metrics of car-
diac chronotropy based on the imported IBI series (IBI values in milli-
seconds). The IBI series is ﬁrst converted to an IBI time-series by linear
interpolation at 10 Hz, resulting in a time-series that is appropriate for
frequency analyses. Epochs comprising fetal breathing were analyzed
separately from those comprising non-breathing (Apnea). We used
the following metrics from the CMetX output:
1. A putative parasympathetic metric, the natural log of the variance
in the band-limited IBI time-series (Log RSA). The band-limited
signal was selected to capture the breathing frequency of the
fetus and neonate (0.4-1.7 Hz); [14], and following ﬁltering of
the IBI time-series in this band, the natural log of the variance in
this ﬁltered time series yields the metric Log RSA
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Fig. 1. An example of a reconstructed fetal diaphragmatic magnetomyogram (dMMG) in channel space. After independent component analysis, the components linked to fetal
breathing activity are reconstructed in channel space. The designations on the Y-axis are channel numbers assigned to the 83 channel system based on their location. The X-axis
represents time in seconds. At zero seconds, fetal dMMG at a frequency of approximately 1.1 Hz is observed, lasting for about 48 s. At 60 s, a period of fetal apnea begins. In this
particular case, fetal dMMG was observed at the end of the previous 6 minute dataset so this segment of breathing activity represents the last 48 s of that entire segment. This
shorter segment is shown only to illustrate the morphology of the waveform and to demonstrate the distinctive difference between breathing and non-breathing activity
(apnea). Areas of disorganized activity that likely represent the transition from breathing activity to apnea are in the shaded area and are not included in the analysis.
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thetic and sympathetic activity which include:
a. The root mean square of successive differences between con-
secutive IBIs (RMSSD)
b. The natural Log of the variance in the IBI time-series (Log HRV)
3. Metrics of rate (mean IBI, mean HR) which are inﬂuenced by both
parasympathetic and sympathetic activity
We also used a template-matching algorithm developed by our
team [15] in EEGLab 4.311 [10] to automatically detect R-peaks for
frequency domain analysis. False positive and false negative detec-
tions and abnormal beats were manually corrected. After generating
the IBI time-series using the 10 Hz linear interpolation described
above, we implemented a time-frequency analysis that was modi-
ﬁed to provide a speciﬁed frequency resolution (0.0–1.7 Hz). The
output from time-frequency analysis (power integral of deﬁned fre-
quency bands expressed in ms2) is based on the work of David et al.
[16], using the following frequency bands for fetal HRV analysis:
very low frequency (VLF) [0.02–0.08 Hz], low frequency (LF)
[0.08–0.2 Hz], intermediate (INT) [0.2–0.4 Hz], high frequency (HF)
[0.4–1.7 Hz] and Total Power, [0.02–1.7 Hz]. Total Power is a mea-
sure of total HRV as the band encompasses all frequencies. The
VLF, LF and INT bands reﬂect contributions from both sympathetic
and parasympathetic activity. The HF band, similar to Log RSA
above, captures the breathing frequency and thus is a parasympa-
thetic metric.2.5. Statistical approach
We ﬁrst examined the distribution of each fetal cardiac metric of
rate and variability deﬁned in Section 2.4. The measures with skewed
distributions were log transformed to make their distribution approx-
imately Gaussian (RMSSD, VLF, LF, INT, HF and Total Power). Two
metrics from CMetX were already natural-log transformed (Log RSA,
Log HRV). Fetal cardiac metrics (either in original or natural log-
transformed scales) were summarized by mean and standard devia-
tion (SD). Because each subject had correlated, repeated fetal HRV
measures during apnea and breathing conditions, we evaluated the
effects of maternal exercise and fetal breathing conditions by the
mixed-effects models using a random intercept. Predictor variables
included group (Control and Exercise), breathing condition (Breath-
ing and Apnea), and their interaction. If the interaction was signiﬁ-
cant, post hoc comparisons were then performed to compare
Exercise vs. Control during each breathing condition and to compare
apnea vs. breathing within Exercise and Control groups separately.
Because some measures showed a signiﬁcant group-by-condition
interaction while other highly correlated measures did not, we ex-
plored the difference in interactions between measures using a bivar-
iate version of mixed-effects models in order to assess the group-by-
condition interactions. The bivariate mixed-models include factors of
measure, group, condition, group-by-condition interaction, and a 3-
way interaction of measure-by-group-by-condition. A signiﬁcant 3-
way interaction would suggest the group-by condition interaction ef-
fects differed between measures.
Table 1
Fetal cardiac metrics during apnea and breathing.
Exercise n=15 Control n=15
[mean±SD] [mean±SD]
Apnea Breathing Apnea Breathing
Epoch duration (s) 87.4±27.7 88.3±27.1 72.5±13.2 72.5±13.3
Parasympathic metrics
Log HF 1.62±0.52 3.02±0.98 1.47±0.60 2.21±0.58
Log RSA 1.34±0.67 2.51±0.98 1.23±0.69 1.87±0.58
Metrics summarizing total HRV
Log RMSSD 1.70±0.35 2.19±0.51 1.58±0.37 1.85±0.29
Log HRV 5.67±1.13 5.61±1.01 5.45±1.08 4.33±0.73
Log total power 4.76±1.06 5.10±1.05 4.66±1.06 4.04±0.72
Other frequency domain metrics
Log VLF 3.93±1.18 3.93±1.36 3.86±1.17 2.68±1.24
Log LF 2.95±1.14 3.33±1.22 2.52±1.58 2.31±0.98
Log INT 1.25±1.12 2.30±1.51 0.86±1.04 1.08±0.87
Metrics of rate
IBI (ms) 428.9±29.6 456.6±29.4 405.9±28.7 423±27.8
HR (bpm) 140.9±9.6 132.2±8.8 148.8±10.5 142.5±9.6
Ratios attributed to sympatho-vagal balance
Log VLF/LF 0.98±0.94 0.61±1.07 1.25±1.23 0.37±1.20
Log VLF/HF 2.31±1.03 0.90±1.26 2.42±1.04 0.32±1.63
Log LF/HF 1.33±0.88 0.31±0.88 1.17±1.15 0.10±1.12
Note: Measures of parasympathetically-controlled heart rate variability include Log
RSA=natural Log of variance of ﬁltered [0.4–1.7 Hz] IBI time-series and high frequen-
cy power (Log HF) [0.4–1.7 Hz]. Time and frequency domain measures of total heart
rate variability include RMSSD = root mean square of differences between IBIs; Log
HRV=natural log of variance of IBI time-series, and Log Total Power [0.02–1.7 Hz].
Other frequency domain measures of band speciﬁc power (integrals in ms2) include
very low frequency (Log VLF) [0.02–0.08 Hz], low frequency (Log LF) [0.08–0.2 Hz],
and intermediate frequency (Log INT) [0.2–0.4 Hz] and their ratios. Assessments of
rate include IBI = mean interbeat interval; HR = mean heart rate. Time domain HRV
metrics are in ms.
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3.1. Summary statistics for metrics of fetal cardiac autonomic control for
main effects and interactions
The mean and standard deviation for each metric by group and
condition are listed in Table 1. Results of the mixed-models and
group-by-condition interactions are listed in Table 2. The results of
the post-hoc comparison are shown in Table 3. Means and standard
errors for all metrics in each group under each condition are shown
in Fig. 2. In Table 3, (Control vs. Exercise — Apnea) we show thatTable 2
Fetal HR and HRV metrics ﬁtted by the mixed models.
Exercise vs. Control Apnea v
Estimate SEb pa Estimat
Epoch duration (s) 15.8 7.86 0.062 −0.94
Log HF 0.81 0.25 0.028 −1.40
Log RSA 0.64 0.27 0.11 −1.17
Log RMSSD 0.34 0.14 0.077 −0.49
Log HRV 1.28 0.37 0.013 0.06
Log Total Power 1.06 0.36 0.057 −0.34
Log VLF 1.25 0.45 0.064 −0.00
Log LF 1.01 0.46 0.069 −0.37
Log INT 1.22 0.42 0.032 −1.05
IBI (ms) 33.6 10.5 0.008 −27.8
HR (bpm) −10.3 3.50 0.01 8.68
Log VLF/LF 0.24 0.41 0.96 0.37
Log VLF/HF 0.59 0.46 0.48 1.40
Log LF/HF 0.20 0.37 0.55 1.02
a Based on Type 3 tests for the ﬁxed effects.
b Mixed models include random intercepts only.the groups are similar during fetal apnea for all HRV metrics with sig-
niﬁcant or marginal interactions.
3.1.1. Parasympathetic metrics
Maternal exercise does not signiﬁcantly increase Log RSA after
adjusting for fetal breathing (p=0.11). During fetal breathing, Log
RSA is signiﬁcantly higher than apnea (pb .0001) after adjusting for
maternal exercise status. Importantly, the group-by-condition inter-
action for Log RSA is marginal (p=0.09) but is signiﬁcant for Log
HF power (p=0.033). The post-hoc comparison reveals that fetal
breathing, when compared to apnea, results in signiﬁcantly greater
Log HF power (p=0.001) and higher Log RSA (p=0.005) in the Con-
trol group and in the Exercise group (both pb .0001), and maternal
exercise increases these two measures during fetal breathing (Log
HF, p=0.004, Log RSA, p=0.026).
3.1.2. Maternal exercise may augment the effects on parasympathetic
metrics
Log RSA and Log HF power are two metrics that are highly corre-
lated (r=.935) and reﬂect respiratory linked variability, but maternal
exercise signiﬁcantly enhances the breathing effects for Log HF power
and is only marginally signiﬁcant for Log RSA. Therefore, we used a bi-
variate mixed-effects model to assess whether the group-by-
condition interactions between measures of Log RSA and Log HF
were signiﬁcantly different. The results showed a non-signiﬁcant 3-
way interaction (F(3,84)=0.46, p=0.71) that indicates the 2-way
group-by-condition interactions were not signiﬁcantly different be-
tween Log RSA and Log HF power. This matched the patterns of
between-condition and between-group differences (ApneabBreath-
ing in both Control and Exercise groups; ControlbExercise during
fetal breathing). In other words, the trend-level group-by-condition
interaction for Log RSA is in fact similar to that seen for Log HF. In sup-
port of this claim are the ﬁndings that Log RSA and Log HF Power
functioned similarly (same signs in estimates and same conclusions
of signiﬁcance) but with Log RSA having slightly smaller magnitude
of effect size, and hence the p-value for Log RSA by group-by-
condition interaction on Log RSA was marginal (0.09). Nonetheless,
in the key comparison of Control vs. Exercise groups during breathing
episodes, both measures perform similarly and signiﬁcantly differen-
tiate Control and Exercise groups (Table 3, far right column).
3.1.3. Metrics summarizing total HRV
After adjusting for the fetal breathing condition, fetuses in the Ex-
ercise group have marginally higher Log RMSSD (p=0.077). During
fetal breathing, Log RMSSD is signiﬁcantly higher than during the ap-
neic condition (pb0.0001).s. Breathing Group-by-condition
e SE pa Estimate SE pa
0.41 0.13 0.97 0.59 0.11
0.21 b.0001 0.65 0.29 0.033
0.21 b.0001 0.52 0.30 0.09
0.10 b.0001 0.22 0.14 0.11
0.33 0.016 1.06 0.46 0.029
0.30 0.62 0.96 0.42 0.029
3 0.42 0.057 1.18 0.59 0.056
0.35 0.74 0.58 0.49 0.25
0.32 0.009 0.83 0.45 0.078
5.22 b.0001 10.7 7.40 0.16
1.65 b.0001 2.36 2.33 0.32
0.41 0.038 0.51 0.58 0.38
0.46 b.0001 0.70 0.65 0.29
0.31 b.0001 0.05 0.44 0.92
Table 3
Post hoc comparison of those variables with marginal† (p between 0.05 and 0.10) and signiﬁcant‡ (p≤0.05) group-by-condition interaction.
Apnea vs. Breathing Apnea vs. Breathing Control vs. Exercise Control vs. Exercise
Control Exercise Apnea Breathing
Est. SE t p Est. SE t p Est. SE t p Est. SE t p
Log HF‡ −0.74 0.21 −3.62 0.001 −1.40 0.21 −6.80 b.0001 −0.16 0.25 −0.61 0.54 −0.81 0.25 −3.19 0.004
Log RSA† −0.65 0.21 −3.04 0.005 −1.17 0.21 −5.50 b.0001 −0.12 0.27 −0.43 0.67 −0.64 0.27 −2.36 0.026
Log HRV‡ 1.12 0.33 3.45 0.002 0.06 0.33 0.19 0.85 −0.22 0.37 −0.61 0.55 −1.28 0.37 −3.51 0.002
Log total power‡ 0.62 0.30 2.09 0.046 −0.34 0.30 −1.16 0.26 −0.10 0.36 −0.27 0.79 −1.06 0.36 −2.95 0.006
Log VLF† 1.18 0.42 2.81 0.009 −0.003 0.42 −0.01 0.995 −0.07 0.45 −0.15 0.88 −1.25 0.45 −2.77 0.010
Log INT† −0.22 0.32 −0.69 0.50 −1.05 0.32 −3.28 0.003 −0.39 0.42 −0.92 0.36 −1.22 0.42 −2.89 0.007
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and Log Total Power (both p=0.029) but not for Log RMSSD
(p=0.11). Because of the interactions, the exercise and breathing ef-
fects were interpreted by post hoc comparison. In the Control group,
fetal breathing reduced both Log HRV and Log Total Power when
compared to apnea (p=0.002 and 0.046, respectively), but not in
the Exercise group. During fetal breathing, the Exercise group showed
greater variability in both measures when compared to the Control
group (Log HRV, p=0.002, Log Total Power, p=0.006).
3.1.4. Other frequency domain metrics
Maternal exercise results in marginally higher Log LF power after
adjusting for fetal breathing (p=0.069). Maternal exercise does not
result in a group difference for the frequency band ratios thought to
reﬂect fetal sympatho-vagal balance (Log VLF/LF p=0.96, Log VLF/
HF p=0.48, Log LF/HF, p=0.55).
There is no signiﬁcant difference in Log LF power during fetal
breathing after adjusting for maternal exercise (p=0.74). The ratios
thought to reﬂect sympatho-vagal balance are all signiﬁcantly lower
during fetal breathing when compared to apnea (Log VLF/LF
p=0.038, Log VLF/HF p=b.0001, Log LF/HF, p=b.0001). No signiﬁ-
cant group-by-condition interactions are seen for Log LF power or
the frequency band ratios.
The group-by-condition interaction is marginally signiﬁcant for
Log VLF (p=0.056) and Log INT power (p=0.078), indicating that
maternal exercise might modify the fetal breathing effects. Results
of the post-hoc comparison show that fetal breathing results in
lower Log VLF in the Control group (p=0.009) but had no effect on
the Exercise group (p=0.995); consequently, there is a signiﬁcant
group difference during fetal breathing (p=0.010). There is no signif-
icant difference in Log INT during fetal breathing in the Control group
(p=.50) however; Log INT is signiﬁcantly increased in the Exercise
group during breathing (p=0.003). During fetal breathing, the Exer-
cise group has greater power in the INT band when compared to the
Control group (p=0.007).
3.1.5. Metrics of rate
Both maternal exercise and fetal breathing result in signiﬁcantly
lower fetal HR. In the Exercise group, the mean IBI is longer
(p=0.008) and, consequently, fetal HR is lower (p=0.01) when
compared to the Control group after adjusting for the fetal breathing
condition. Fetal breathing activity results in a longer IBI and lower HR
compared to the apneic condition (both pb .0001) after adjusting for
maternal exercise status. No group-by-condition interaction was
seen for either metric of fetal HR (IBI, p=0.16; HR p=0.32).
4. Discussion
We compared metrics of fetal HR and HRV during in utero breath-
ing and apneic periods in women who, based on the MPAQ, did or did
not participate in regular aerobic exercise throughout their pregnan-
cy. Using the fetal dMMG as a marker for breathing activity, we com-
pared metrics of fetal HR and HRV in both time and frequencydomains. We examined the main effects of fetal breathing condition
(apnea vs. breathing) and maternal exercise group (Exercise vs. Con-
trol) on fetal HR and HRV and the group-by-condition interaction.
When we examined the main effect of maternal exercise, we
found that maternal exercise was associated with signiﬁcantly lower
fetal HR (longer IBI), higher Total HRV (Log HRV) and higher vagal
input (Log HF power). We did not observe a group difference in the
frequency band ratios, similar to our previous report on the effects
of maternal exercise on fetal cardiac autonomic control [7] suggesting
that maternal exercise does not alter fetal sympatho-vagal balance.
When we examined the main effect of fetal breathing, we found
that fetal breathing movements were associated with signiﬁcantly
lower fetal HR (longer IBI), higher Total HRV (Log RMSSD) and higher
vagal input as indexed by the parasympathetic metrics Log HF power
and Log RSA. Fetal breathing had a greater effect on the parasympa-
thetic metrics than maternal exercise. Consequently, the frequency
band ratios showed signiﬁcantly lower values during fetal breathing,
comparable to the results in our previous report describing the effects
of fetal breathing on cardiac autonomic control [1].
The novel ﬁnding in this report is the signiﬁcant interaction be-
tween maternal exercise and fetal breathing for Log HRV, Log Total
Power, Log VLF, Log INT and Log HF power (Fig. 2). The exercise ef-
fects are only seen during fetal breathing activity, a time when
vagal function is enhanced. However, exposure to maternal exercise
may also prevent sympathetic withdrawal during fetal breathing, if
we assume that there are signiﬁcant sympathetic contributions to
VLF and LF power. Other investigators have concluded that the fetal
VLF band reﬂects primarily sympathetic activity and the LF band has
both sympathetic and parasympathetic components [16]. Attributing
power in the lower frequency bands to speciﬁc contributions from
one or both limbs of the developing autonomic nervous system war-
rants caution. However, there does seem to be general agreement
that fetal breathing activity contributes primarily to HF power
[17–19] although, where the lower cutoff for the HF band is not
clear. David, et al. described a “power gap” in the INT frequency
band (0.2–0.4 Hz) where it was nearly impossible to observe any
power. We agree that this band has the least power, but it is not with-
out signiﬁcance. Our results show an increase in Log INT power dur-
ing fetal breathing movements for the Exercise group, and for both
groups in Log HF power and Log RSA. Despite not being able to un-
equivocally assign speciﬁc contributions of one or both limbs of the
autonomic nervous system to the lower frequency bands, based on
the results of the group-by-condition interactions, we conclude that
the fetus of the exercising mother is more able to initiate greater
vagal activation with less sympathetic withdrawal during breathing
activity. This suggests that maternal exercise results in a more ﬂexi-
ble, responsive and adaptive autonomic nervous system in the fetus.
Our results are important for two reasons. First, they show that that
fetal breathing activity strongly inﬂuences HRV and needs to be
accounted for when comparing group differences. Second, while the
actions of the sympathetic and parasympathetic nervous systems
are often regarded as opposing each other, they can function in syner-
gy. It has been shown that simultaneous activation of the vagal and
Fig. 2. Means and standard errors of the group-by-condition interactions for fetal heart rate variability (HRV) and heart rate (HR) metrics used in the analysis. Asterisks denote signiﬁcant interactions between maternal exercise and fetal
breathing (p≤0.05). Abbreviations: RMSSD = root mean square of successive difference, RSA = respiratory sinus arrhythmia. Frequency domain HRV measures: Total Power (log Total Power), [0.02–1.7 Hz].very low frequency (log VLF)
[0.02–0.08 Hz], low frequency (log LF) [0.08–0.2 Hz], intermediate (log INT) [0.2–0.4 Hz], and high frequency (log HF) [0.4–1.7 Hz].
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lower HR [20]. While power in deﬁned frequency bands cannot be
used as a proxy for cardiac output, the ﬁnding is intriguing and war-
rants further investigation.
Fetal breathing has been shown in both humans [1] and animals
[21–23] to result in lower HR and higher parasympathetic-
dominated HRV. How maternal exercise inﬂuences fetal cardiac auto-
nomic function is less clear.
4.1. Potential mechanisms of the effect of maternal exercise on fetal car-
diac control
Aerobic exercise can increase activity of the parasympathetic ner-
vous system and decrease sympathetic activity [24]. At rest, the con-
ditioned individual has lower HR and increased parasympathetic
input compared with a sedentary individual; therefore, one would as-
sume greater parasympathetic input at rest to represent the healthy
state of autonomic balance. Autonomic imbalance with greater sym-
pathetic input is associated with obesity [25], insulin resistance
[26,27], diabetes [28] and cardiovascular disease [29]. Exercise is
anti-inﬂammatory, anti-oxidant and anti-atherogenic [30]. These ef-
fects may be ascribed to some extent to an increase in cholinergic
anti-inﬂammatory pathway activity. Acetylcholine, the primary
vagal neurotransmitter, is considered an anti-inﬂammatory molecule
due to its ability to attenuate the release of pro-inﬂammatory cyto-
kines [31]. Interestingly, there is evidence of interaction between ace-
tylcholine and long-chain polyunsaturated fatty acids [32,33]. During
the third trimester, there is increasedmaternal transfer of docosahex-
aenoic acid (DHA) to the fetus. DHA has also been shown to lower HR
and enhance parasympathetic control [34,35]. We did not see an ef-
fect of maternal exercise on fetal cardiac autonomic control in our
previous longitudinal study until 36 weeks GA. It is conceivable that
exercise may inﬂuence DHA incorporation into fetal cell membranes
based on the work of Chytrova, et al, who showed that exercise can
complement the action of DHA and may play a role in membrane sta-
bility and ﬂuidity [36]. Since DHA is abundant in all cell membranes
and dietary supplementation has been shown to lower HR in the in-
fant and fetus, [37,38] it is not inconceivable that there may be a syn-
ergistic effect of maternal exercise and DHA that results in lower fetal
HR and higher HRV. Therefore, maternal DHA status will be an impor-
tant consideration in future studies.
4.2. Limitations of the present sample
This was a non-randomized, observational pilot study with a rela-
tively small sample of pregnant women who, based on the MPAQ, did
or did not exercise during pregnancy. While there is inherent bias as-
sociated with questionnaires, the tool used in this study has been
shown to be a reliable and valid instrument for assessing the intensity
and duration of physical activities performed in the preceding
12 months in various populations, including pregnant women
[39,40]. Because of the non-randomized nature of the sample, it is
possible that a variable other than exercise might account for the
ﬁndings (i.e., a third-variable problem), whereby an individual differ-
ence in the mothers impacts both the likelihood of exercise and fac-
tors related to fetal autonomic function. Nonetheless, the present
ﬁndings support the promise of a larger randomized controlled trial
of maternal exercise on fetal cardiac autonomic control during
pregnancy.
Due to the sensitivity and precision of the biomagnetometer and
our ability to observe simultaneous fetal dMMG and MCG activity
we were able to capture data with no loss of signal. To our knowledge,
we are the only group to use the dMMG as a marker for human fetal
breathing activity with the purpose of comparing fetal HR and HRV
during breathing and apneic periods. Due to the periodic nature of
fetal breathing activity, these recordings are unavoidably short.Nonetheless, frequency domain measures, especially HF components
of HRV, can be assessed in as little as 1 min [41]. This is a novel area
of HRV research that allows us to investigate the longitudinal devel-
opment of fetal cardiac autonomic function during different fetal
behaviors.
4.3. Implications
In a healthy pregnancy, there are myriad maternal physiologic and
cardiovascular adaptations to prevent rejection of the fetus and sup-
port fetal growth. These include modiﬁcations to the innate immune
system [42], alterations in cytokine production [43], increased insulin
resistance [44] and changes in autonomic circulatory function that re-
sult in an increasingly hyper-sympathetic maternal state as gestation
progresses [45]. When these normal adaptations are complicated by
excess maternal weight and inﬂammation, then pregnancy can be
complicated by gestational diabetes, pre-eclampsia, abnormal placen-
tal development and pre-term delivery [46].
It is now clear that a sedentary lifestyle increases metabolic dis-
ease risk. The consequences of maternal over-nutrition, obesity, ges-
tational diabetes leading to increased risk for metabolic disorders in
the offspring are already evident. Furthermore, there is now convinc-
ing evidence that these maternal complications can have long-term
health consequences for the next generation [47]. Maternal exercise
is associated with lower fetal HR and higher HRV in both time and fre-
quency domains. Furthermore, during in utero breathing movements,
the fetus of the exercising mother is able to exert greater cardiac au-
tonomic input, suggesting a programming effect that may give the
offspring an adaptive advantage with respect to cardiac autonomic
function.
The question remains as to whether these effects of maternal ex-
ercise offer a transitory or long-lasting beneﬁt to the offspring. This
is an area of continuing and future investigation. Exercise is a natural,
holistic and often overlooked therapy that has the potential to
counter-balance the natural physiologic changes in pregnancy. We
suggest that moderate maternal exercise during pregnancy may
help reduce the risks associated with excess maternal weight gain
and inﬂammatory conditions of pregnancy.
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